logo
Court overturns massive coal mine approval on climate grounds

Court overturns massive coal mine approval on climate grounds

The Age6 days ago
A court has overturned the 2022 approval of a massive Hunter Valley coal mine in a landmark ruling that sets a clear precedent that planning authorities must consider the local impact of global climate change.
The decision by the full bench of the NSW Court of Appeal invalidates the permission for Indonesian company MACH Energy to extend the Mount Pleasant coal mine near Muswellbrook for another 22 years after its current approval expires in 2026.
The project would generate emissions equivalent to 876 megatonnes of carbon dioxide, planning documents say, and about 98 per cent of that would be from customers burning the coal overseas.
Elaine Johnson, the environmental lawyer for Denman, Aberdeen, Muswellbrook and Scone Healthy Environment Group, said it was a 'significant decision for climate change considerations on new and expanded fossil fuel projects in NSW'.
'The fact that the emissions will be generated overseas does not make any difference to the mandatory duty of the NSW Independent Planning Commission to look at what the likely impacts of this coal mine expansion will be on the local community and the people in the environment of NSW,' Johnson said.
'This covers all projects, not just this particular mine – it is, of course, highly relevant to any applications for fossil fuel projects in NSW.'
Anti-fossil fuels group Lock the Gate says there are 18 coal proposals at various stages in the NSW planning system.
The court found that the Independent Planning Commission must consider the causal link between the project's scope-three emissions and climate change, and the effect that would have on the locality of the Mount Pleasant mine.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Owners of Bowen Basin mine enter administration amid coal price slump
Owners of Bowen Basin mine enter administration amid coal price slump

ABC News

time20 hours ago

  • ABC News

Owners of Bowen Basin mine enter administration amid coal price slump

A mining giant in charge of a steel-making coal mine in north Queensland's Bowen Basin has entered liquidation after a series of claims totalling more than $29 million from a former contractor. It has left about 500 jobs at Bowen Coking Coal's Burton Coal Complex in doubt. Mark Holland and Shaun Fraser from restructuring firm McGrathNicol have been appointed as voluntary administrators. In a statement, they said Bowen Coking Coal's operations would continue to trade on a "business-as-usual basis while a sale and/or recapitalisation process is undertaken". "This includes the operations at the Burton Mine Complex located in the Bowen Basin of Queensland, which will continue uninterrupted," the statement said. A meeting of creditors will be held by August 8. Bowen Coking Coal bought the Burton Coal Complex, north of Moranbah, in 2021. Indonesian contractor BUMA Australia had operated the mine for the past two years, before its agreement expired on June 30, 2025, leaving the owners to oversee operations. Bowen Coking Coal advised investors it had received a letter of demand for payment of invoices totalling $15,288,017 from BUMA on June 15. In a statement to the Australian Stock Exchange on Wednesday, the mine owner announced that it had failed to make arrangements with its two largest creditors, BUMA Australia and the Queensland Revenue Office (QRO). It said a decision to appoint administrators came after its request to the QRO to defer royalty payments was rejected. The company's board stated the decision "reflects the current challenging environment for the coal industry in Queensland from higher costs, lower global coal prices and higher royalty rates introduced by the Queensland government in 2022". The Queensland Resources Council said operating conditions in the coal industry had become extremely difficult. "The announcement will cause deep uncertainty for hundreds of Queensland workers and their families who face the prospect of losing their jobs if the Burton Mine closes permanently," chief executive Janette Hewson said. She said other mining companies could face similar struggles, with coal prices falling close to 17 per cent lower than they were a year ago. "Energy and production costs have risen significantly for coal producers while coal prices are stubbornly low and Queensland producers are paying the world's highest coal royalty tax rates," Ms Hewson said. BUMA Australia declined to comment.

US reaches new trade deal with European Union
US reaches new trade deal with European Union

AU Financial Review

time3 days ago

  • AU Financial Review

US reaches new trade deal with European Union

Global pharmaceutical giants, including Pfizer and Johnson & Johnson, are paying a tiny fraction of the billions of dollars they earn from drug sales in local taxes, at a time when they're lobbying US President Donald Trump to force an overhaul of Australia's Pharmaceutical Benefits Scheme. An analysis of earnings statements filed with the corporate regulator by five of the biggest US and European drugmakers shows the companies on average pay between 2 per cent and 4 per cent of their Australian sales in income tax. The numbers may make for uncomfortable reading for drug multinationals as they step up efforts to loosen the PBS' grip on the pricing of key medicines.

Drug giants targeting Australia's PBS are paying tiny amounts of tax
Drug giants targeting Australia's PBS are paying tiny amounts of tax

AU Financial Review

time3 days ago

  • AU Financial Review

Drug giants targeting Australia's PBS are paying tiny amounts of tax

Global pharmaceutical giants, including Pfizer and Johnson & Johnson, are paying a tiny fraction of the billions of dollars they earn from drug sales in local taxes, at a time when they're lobbying US President Donald Trump to force an overhaul of Australia's Pharmaceutical Benefits Scheme. An analysis of earnings statements filed with the corporate regulator by five of the biggest US and European drugmakers shows the companies on average pay between 2 per cent and 4 per cent of their Australian sales in income tax.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store